Holdings of the Fund as of 5/6/2026
Total Number of Holdings (excluding cash): 30
| Veracyte, Inc. |
VCYT |
92337F107 |
Health Care |
2,430,849 |
$100,126,670.31 |
4.13% |
| Axsome Therapeutics, Inc. |
AXSM |
05464T104 |
Health Care |
424,317 |
$94,465,693.71 |
3.90% |
| Corcept Therapeutics Inc. |
CORT |
218352102 |
Health Care |
1,803,271 |
$94,040,582.65 |
3.88% |
| Arrowhead Pharmaceuticals, Inc. |
ARWR |
04280A100 |
Health Care |
1,160,195 |
$91,817,832.30 |
3.79% |
| Illumina, Inc. |
ILMN |
452327109 |
Health Care |
624,949 |
$89,105,228.42 |
3.68% |
| NeoGenomics, Inc. |
NEO |
64049M209 |
Health Care |
9,827,710 |
$87,368,341.90 |
3.61% |
| Neurocrine Biosciences, Inc. |
NBIX |
64125C109 |
Health Care |
586,353 |
$86,205,618.06 |
3.56% |
| Bruker Corporation |
BRKR |
116794108 |
Health Care |
2,010,510 |
$85,044,573.00 |
3.51% |
| Krystal Biotech, Inc. |
KRYS |
501147102 |
Health Care |
291,796 |
$84,326,126.04 |
3.48% |
| Natera, Inc. |
NTRA |
632307104 |
Health Care |
391,519 |
$84,211,821.71 |
3.48% |
| Biogen Inc. |
BIIB |
09062X103 |
Health Care |
436,925 |
$83,312,859.00 |
3.44% |
| Exelixis, Inc. |
EXEL |
30161Q104 |
Health Care |
1,707,141 |
$83,137,766.70 |
3.43% |
| Sarepta Therapeutics, Inc. |
SRPT |
803607100 |
Health Care |
3,568,230 |
$82,176,336.90 |
3.39% |
| Alkermes Plc |
ALKS |
G01767105 |
Health Care |
2,265,441 |
$80,015,376.12 |
3.30% |
| Repligen Corporation |
RGEN |
759916109 |
Health Care |
629,268 |
$79,136,743.68 |
3.27% |
| United Therapeutics Corporation |
UTHR |
91307C102 |
Health Care |
132,187 |
$78,883,914.12 |
3.26% |
| ADMA Biologics, Inc. |
ADMA |
000899104 |
Health Care |
7,790,444 |
$78,527,675.52 |
3.24% |
| Incyte Corporation |
INCY |
45337C102 |
Health Care |
786,667 |
$78,548,699.95 |
3.24% |
| BeOne Medicines Ltd. (ADR) |
ONC |
07725L102 |
Health Care |
244,059 |
$76,468,565.88 |
3.16% |
| argenx SE (ADR) |
ARGX |
04016X101 |
Health Care |
94,510 |
$76,321,550.50 |
3.15% |
| BioMarin Pharmaceutical Inc. |
BMRN |
09061G101 |
Health Care |
1,385,935 |
$75,672,051.00 |
3.12% |
| BioNTech SE (ADR) |
BNTX |
09075V102 |
Health Care |
791,363 |
$75,385,239.38 |
3.11% |
| Genmab A/S (ADR) |
GMAB |
372303206 |
Health Care |
2,675,224 |
$74,611,997.36 |
3.08% |
| Gilead Sciences, Inc. |
GILD |
375558103 |
Health Care |
543,588 |
$74,091,044.40 |
3.06% |
| Vertex Pharmaceuticals Incorporated |
VRTX |
92532F100 |
Health Care |
173,230 |
$74,081,809.50 |
3.06% |
| Halozyme Therapeutics, Inc. |
HALO |
40637H109 |
Health Care |
1,114,348 |
$73,936,989.80 |
3.05% |
| Regeneron Pharmaceuticals, Inc. |
REGN |
75886F107 |
Health Care |
100,919 |
$72,767,644.95 |
3.01% |
| Alnylam Pharmaceuticals, Inc. |
ALNY |
02043Q107 |
Health Care |
234,605 |
$71,085,315.00 |
2.94% |
| Amgen Inc. |
AMGN |
031162100 |
Health Care |
215,314 |
$71,292,618.54 |
2.94% |
| Bio-Techne Corporation |
TECH |
09073M104 |
Health Care |
1,360,733 |
$64,505,547.88 |
2.66% |
| US Dollar |
$USD |
|
Other |
860,028 |
$860,027.84 |
0.04% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|